GlassScriptPhysician profile
Erik Goluboff
NPI 1629012174
$45,524.88
in general payments reported to CMS, 2019-2025
16 companies · $272 in 2025
The $272 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31K · 2020: $14K · 2022: $43.78 · 2023: $230 · 2025: $272.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $502.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $502.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $31,239.47 | 2019-2020 | |
| Pfizer INC. | $13,147.87 | 2019-2020 | |
| Koelis INC. | $230.05 | 2023 | |
| Boston Scientific Corporation | $216.14 | 2019-2020 | |
| Calyxo, INC. | $137.67 | 2025 | Cvac Aspiration System |
| Genentech USA, INC. | $134.57 | 2025 | |
| Janssen Biotech, INC. | $96.64 | 2019-2020 | |
| Blue Earth Diagnostics | $84.92 | 2019 | |
| Janssen Scientific Affairs, LLC | $57.56 | 2019 | |
| Antares Pharma, INC. | $43.78 | 2022 | |
| Rochester Medical Corporation | $24.54 | 2020 | |
| Ferring Pharmaceuticals INC. | $24.33 | 2020 | |
| Endo Pharmaceuticals INC. | $24.17 | 2019 | |
| Coloplast Corp | $21.27 | 2019 | |
| Abbvie INC. | $21.23 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $20.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erik Goluboff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.